An in vivo gene amplification system for high level expression in Saccharomyces cerevisiae
Bingyin Peng,Lygie Esquirol,Zeyu Lu,Qianyi Shen,Li Chen Cheah,Christopher B. Howard,Colin Scott,Matt Trau,Geoff Dumsday,Claudia E. Vickers
DOI: https://doi.org/10.1038/s41467-022-30529-8
IF: 16.6
2022-05-24
Nature Communications
Abstract:Abstract Bottlenecks in metabolic pathways due to insufficient gene expression levels remain a significant problem for industrial bioproduction using microbial cell factories. Increasing gene dosage can overcome these bottlenecks, but current approaches suffer from numerous drawbacks. Here, we describe HapAmp, a method that uses haploinsufficiency as evolutionary force to drive in vivo gene amplification. HapAmp enables efficient, titratable, and stable integration of heterologous gene copies, delivering up to 47 copies onto the yeast genome. The method is exemplified in metabolic engineering to significantly improve production of the sesquiterpene nerolidol, the monoterpene limonene, and the tetraterpene lycopene. Limonene titre is improved by 20-fold in a single engineering step, delivering ∼1 g L −1 in the flask cultivation. We also show a significant increase in heterologous protein production in yeast. HapAmp is an efficient approach to unlock metabolic bottlenecks rapidly for development of microbial cell factories.
multidisciplinary sciences